GlassScriptPhysician profile
Eric G Peterson
NPI 1942482047
$8,940.92
in general payments reported to CMS, 2019-2025
21 companies · $35.33 in 2025
The $35.33 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $210 · 2021: $12.00 · 2022: $7,976 · 2023: $322 · 2025: $35.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,254.00 | 2022-2023 | Da Vinci Surgical System |
| Pulmonx Corporation | $505.74 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $277.68 | 2019-2023 | Opsumit, Uptravi |
| Abiomed | $195.85 | 2019 | |
| Ethicon INC. | $153.90 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $113.18 | 2022-2023 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $72.66 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.17 | 2019-2023 | Stiolto Respimat |
| Genentech USA, INC. | $47.95 | 2020 | |
| United Therapeutics Corporation | $41.72 | 2022-2023 | Tyvaso |
| Teleflex LLC | $40.00 | 2022 | |
| Glaxosmithkline, LLC. | $30.79 | 2023-2025 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $25.80 | 2023 | Glassia |
| Grifols USA, LLC | $24.75 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.80 | 2023 | Acthar |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.24 | 2023 | |
| Philips North America LLC | $14.26 | 2019 | |
| Harmony Biosciences LLC | $14.12 | 2023 | Wakix |
| Amgen INC. | $13.53 | 2023 | Tezspire |
| Mylan Specialty L.P. | $13.35 | 2022 | |
| Shire North American Group INC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.